IO Biotech
DenmarkEntry
2019
Hold
7yr
Status
Active
Who owns IO Biotech?
IO Biotech is currently owned by Eurazeo through Kurma Biofund III (2017 vintage), since 2019. Across its history, IO Biotech has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
EurazeoKurma Biofund III · 2017 · Healthcare
3 ownership periods · full history below
Key facts
Key takeaways
- ·Held by Eurazeo since 2019 (7Y hold).
- ·Average hold across 2 realized cycles: 6 years.
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2015 · present
Lundbeckfonden BioCapitalExited 2021
2015 · 2021(6yr) · Lundbeckfonden BioCapital · 2009 · Life Sciences VC
IPO
MOIC
–
Sunstone Life Science VenturesExited 2021
2015 · 2021(6yr) · Sunstone Life Science Ventures IV · 2015 · VC
IPO
MOIC
–
EurazeoActive
2019 · present(7yr) · Kurma Biofund III · 2017 · Healthcare
More from Kurma Biofund III
Other portfolio companies in the same fund.
France
Netherlands
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack IO Biotech
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy IO Biotech?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on IO Biotech.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue